Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 701–800 of 999
Youl, E., Ouédraogo, C. A. P., Gambo, M., Ouédraogo, M., Kiendrébeogo, M., Traoré, A., & Guissou, I. P. (2019) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0176 · Cited by 14
Yang, X., Zhang, P., Zhang, F., Ke, Z., Chen, Q., & Liu, C. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29588 · Cited by 11
“Besides, accumulating epidemiological evidence suggested that diabetes mellitus patients were at risk of developing hepatic steatosis as well.(40) Consistently, experimental studies also demonstrated hepatic steatosis formation in our diabetic model mice.”
BackgroundUtzschneider, K., Johnson, T. N., Breymeyer, K. L., Bettcher, L. F., Raftery, D., Newton, K., & Neuhouser, M. (2020) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2020.107586 · Cited by 9
Beta-Cell Function and Failure in Type 2 Diabetes
Popa, S. G., & Mot, M. (2013) · InTech eBooks · doi:10.5772/56467 · Cited by 17
“• Decreased insulin gene expression via activation of JNK pathway, also by posttranscrip‐ tional loss of PDX-1 and posttranslational loss of MafA [21,52,101].”
BackgroundInfluentialFerreira, M. D. R., Chicco, A. G., & Lombardo, Y. B. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.04.006 · Cited by 11
Takita, M., Matsumoto, S., Noguchi, H., Shimoda, M., Chujo, D., Itoh, T., Sugimoto, K., Tamura, Y., Olsen, G. S., Naziruddin, B., et al. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.05.102 · Cited by 11
Sharma, T., Gupta, A., Delhiwala, K., Raman, R. G., Srinivasan, S., & Kulothungan, V. (2016) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.187668 · Cited by 12
“[24] Patients presenting with significant hyperglycemia may benefit from timely initiation of insulin therapy that can effectively and rapidly correct their metabolic imbalance and reverse the deleterious effects of excessive glucose (glucotoxicity) and lipid (lipotoxicity) exposure on β‐cell function and insulin acti…”
BackgroundSuarsana, I. N., Utama, I. H., & Kardena, I. M. (2016) · Asian Journal of Biochemistry · doi:10.3923/ajb.2016.177.185 · Cited by 14
Nikolaidis, M. G., Kerksick, C. M., Lamprecht, M., & McAnulty, S. R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/407978 · Cited by 16
Contreras-Zentella, M. L., Hernández-Espinosa, L. C., & Hernández-Muñoz, R. (2025) · Antioxidants · doi:10.3390/antiox14121494 · Cited by 19
“This vulnerability contributes to glucotoxicity, which accelerates the progression of T2DM by disrupting prostaglandin signaling and promoting mitochondrial dysfunction [75,76].”
Temporal optimization of exercise to lower fasting glucose levels
Kanaley, J. A., Porter, J. W., Winn, N. C., Lastra, G., Chockalingam, A., Pettit‐Mee, R. J., Petroski, G. F., Cobelli, C., Schiavon, M., & Parks, E. J. (2023) · The Journal of Physiology · doi:10.1113/jp285069 · Cited by 12
“The development of insulin resistance leads to elevated fasting and postprandial glucose levels due to impaired tissue glucose uptake, pancreatic β -cell dysfunction and increased endogenous glucose production (EGP) (Poitout & Robertson, 2008; Robertson, 2004).”
Unlocking β-cell restoration: The crucial role of PDX1 in diabetes therapy
Siwan, D., Nandave, M., Gilhotra, R. M., Almalki, W. H., Gupta, G., & Gautam, R. K. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155131 · Cited by 11
Allamreddy, S. R., Arora, M., Ganugula, R., Friend, R., Basu, R., & Kumar, M. N. V. R. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001074 · Cited by 12
Levi-D’Ancona, E., Walker, E. M., Zhu, J., Deng, Y., Sidarala, V., Stendahl, A. M., Reck, E. C., Henry-Kanarek, B. A., Lietzke, A. C., Chai, B., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw4153 · Cited by 14
Roles of GTP and Rho GTPases in pancreatic islet beta cell function and dysfunction
Kowluru, A. (2020) · Small GTPases · doi:10.1080/21541248.2020.1815508 · Cited by 10
Seo, D. H., Kim, M., Suh, Y. J., Cho, Y., Ahn, S. H., Hong, S., & Kim, S. H. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111098 · Cited by 16
Wang, W.-H., Wu, F.-H., Yang, Y., Wu, N., Zhang, J.-S., Feng, N., & Tang, C.-H. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/783460 · Cited by 10
Suarsana, I. N., Utama, I. H., Agung, I. G., & Suartini, A. (2011) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v43n2.46 · Cited by 16
Riccillo, F. L., Bracamonte, M., Montenegro, S. M., Martínez, S. M., & Ronderos, J. R. (2012) · Tissue and Cell · doi:10.1016/j.tice.2011.12.002 · Cited by 12
The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice
Guo, W., Gong, Y., Fu, Z., Fu, J., Sun, Y., Ju, X., Chang, Y., Wang, W., Zhu, X., Gao, B., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0082-1 · Cited by 9
“It has been suggested that increased free fatty acids accumulation in beta cells could reduce insulin secretion from beta cell, and induce beta cell apoptosis [3].”
BackgroundShi, X., Shi, Y., Chen, N., Lin, M., Su, W., Zhang, H., Liu, C., Song, H., Xiao, F., Huang, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02631-1 · Cited by 10
Shiri‐Shahsavar, M. R., Alijani, S., Parsamanesh, N., Nazari, S. S., Moazzen, S., Majnouni, A., Sadeghi, N., & Rasouli, A. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100476 · Cited by 14
Park, C. H., Noh, J. S., Park, J. C., & Yokozawa, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/736856 · Cited by 14
Thorens, B. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.006 · Cited by 14
Lipotoxicity impairs incretin signalling
Poitout, V. (2012) · Diabetologia · doi:10.1007/s00125-012-2788-6 · Cited by 14
“Second, glucotoxicity and lipotoxicity are known to synergistically impair beta cell function, a phenomenon referred to as glucolipotoxicity [7].”
Self-citationLee, K., Seo, Y. J., Kim, M.-K., Seo, H.-A., Jeong, J.-Y., Choi, H., Lee, I., & Park, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.098 · Cited by 10
Linking Fatty Acid Stress to β-Cell Mitochondrial Dynamics
Wiederkehr, A., & Wollheim, C. B. (2009) · Diabetes · doi:10.2337/db09-0967 · Cited by 11
“Possibly the main finding of this study is that a combination of fatty acid and high glucose concentrations, conditions of glucolipotoxicity (13), almost abolished fusion/fission activity, also resulting in pronounced mitochondrial fragmentation (Fig.”
BackgroundHamlat, N., Forcheron, F., Neggazi, S., del Carmine, P., Feugier, P., Bricca, G., Bouguerra, S. A., & Beylot, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-64 · Cited by 12
“The presence in these pathological situations of excessive TG accumulation in non-adipose tissues, previously reported in liver [35,44], skeletal muscle [45,46], endocrine pancreas [47] and heart [48,49], is thus extended to arterial wall.”
BackgroundSuh, K. S., Chon, S., & Choi, E. M. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3620 · Cited by 10
“ROS can be generated from a non‐mitochondrial origin (Jezek & Hlavata, 2005); however, under metabolic stress, the mitochondria are the major source of ROS in pancreatic β‐cells (Poitout & Robertson, 2008).”
BackgroundAhmed, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_16 · Cited by 10
Mummey, H. M., Elison, W. S., Korgaonkar, K., Elgamal, R. M., Kudtarkar, P., Griffin, E. N., Benaglio, P., Miller, M., Jha, A., Fox, J. E. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.03.606460 · Cited by 10
Lu, H., Yang, J., Li, J., & Yuan, H. (2022) · PeerJ · doi:10.7717/peerj.13849 · Cited by 9
“Under glucotoxic conditions, elevated plasma glucose leads to pancreatic β-cell apoptosis and dysfunction which further exacerbates the disease (Poitout & Robertson, 2008).”
BackgroundAkl, M. M., & Ahmed, A. K. K. (2024) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.049 · Cited by 12
“15,16 Furthermore, glucolipotoxicity induces endoplasmic reticulum (ER) stress, characterized by the accumulation of unfolded or misfolded proteins within the ER.”
BackgroundSaadi, H. F., Zamani, M., Koohpeyma, F., Raeisi, A., Amirahmadi, Z., Rezaei, N., Joolidehpoor, Z., Shams, M., & Dastghaib, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09907-6 · Cited by 11
“Following ERS, the UPR, autophagy, and cell death are activated [6].”
InfluentialGu, J., Wei, Q., Zheng, H., Meng, X., Zhang, J., & Wang, D. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5294025 · Cited by 9
Yu, H., Tang, H., Hu, G., Chen, Z., Guo, M., Jiang, B., Zhang, E., & Hu, C. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00848-z · Cited by 9
“However, in the case of T2DM, pancreatic β-cells become unable to secrete sufficient insulin to adequately address the metabolic needs of insulin-responsive tissues [28–30].”
BackgroundWang, Y., Wu, H., Gao, L., Chen, S., Gu, L.-Z., Ding, Z., & Guo, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.003 · Cited by 10
“1A-F), which is a significant risk for this disease (Poitout and Roberson, 2008; Cnop, 2008).”
BackgroundMethodKwon, M. J., Chung, H. S., Yoon, C. S., Ko, J. H., Jun, H. J., Kim, T. K., Lee, S. H., Ko, K. S., Rhee, B. D., Kim, M.-K., et al. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.480 · Cited by 9
“The term glucolipotoxicity has emerged after recognition that the alterations in intracellular lipid partitioning underlying the mechanisms of lipotoxicity are dependent upon elevated glucose levels [17].”
BackgroundGu, H., Xia, X., Chen, Z., Liang, H., Yan, J., Xu, F. L., & Weng, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12095 · Cited by 11
“insulin secretion, defective β-cell proliferation, and/or increased β-cell apoptosis.(2,3) Follow-up studies of the Diabetes Control and Complications Trial–the Epidemiology of Diabetes Intervention and Complications Study (DCCT-EDIC), and the UK Prospective Diabetes Study (UKPDS) showed prior intensive glycemic contr…”
BackgroundRisk of hypoglycemia in youth with type 2 diabetes on insulin
Shahid, M., Shaibi, G. Q., Baines, H., Garcia-Filion, P. C., Gonzalez-Garcia, Z., & Olson, M. L. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0014 · Cited by 9
Raish, M., Ahmad, A., Jan, B. L., Alkharfy, K. M., Kazi, M., Ahamad, S. R., & Ansari, M. A. (2017) · Natural Product Communications · doi:10.1177/1934578x1701200423 · Cited by 9
“The notion of β cell glucotoxicity implies that hyperglycemia can exert toxic consequences on β cell function after the induction of diabetes by genetic or environmental factors or chemicals [1].”
BackgroundShi, R., Li, X., Gao, B., Zhang, C., & Li, M. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.02.016 · Cited by 9
Glucose Mediated Regulation of Beta Cell Proliferation
García-Ocaña, A. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010055 · Cited by 11
Slavov, E., Georgiev, I. P., Dzhelebov, P., Kanelov, I., Andonova, M., Georgieva, T. M., & Dimitrova, S. (2010) · Veterinary Research Communications · doi:10.1007/s11259-010-9345-x · Cited by 10
“For example, it is considered, that increased concentration of free or non-esterified fatty acids in obesity, causes not only insulin resistance but also suppression of insulin secretion ( Pitout and Robertson 2008 ).”
BackgroundGao, L., Tang, W., Ding, Z., Dingyu, W., Qi, X., Wu, H., & Guo, J. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00235 · Cited by 10
Okamoto, T., Park, C. H., Noh, J. S., Toriizuka, K., Sei, Y., Park, J. C., & Yokozawa, T. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01299.x · Cited by 10
Type 2 Diabetes Mellitus Phenotype and Graft Survival After Islet Transplantation
Leitão, C. B., Bernetti, K., Tharavanij, T., Cure, P., Ricordi, C., & Alejandro, R. (2009) · Transplantation · doi:10.1097/tp.0b013e3181aa7cc2 · Cited by 9
“Moreover, the high blood glucose associated with increased levels of free fatty acids, which is a characteristic of insulin resistance states, can lead to beta-cell gluco- and lypotoxicity (14), increasing the beta-cell losses even further.”
BackgroundAbnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 18
The impact of obesity on predisposed people to type 2 diabetes: Mathematical model
Boutayeb, W., Lamlili, M. E. N., Boutayeb, A., & Derouich, M. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16483-0_59 · Cited by 8
Anti diabetic activity of L-Alaninium maleate (LAM) macro and nano crystals
SenthilKannan, K., Kumari, A., Chinnaiyan, U., Paramasivam, S., & Abishek, B. J. S. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.01.548 · Cited by 8
FFAR Out New Targets for Diabetes
Prentice, K. J., & Wheeler, M. B. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.015 · Cited by 8
Dysregulation of Hnf1b Gene Expression in Cultured Beta-Cells in Response to Cytotoxic Fatty Acid
Johnstone, K. A., Diakogiannaki, E., Dhayal, S., Morgan, N. G., & Harries, L. W. (2011) · PubMed · doi:10.6092/1590-8577/3376 · Cited by 9
“After the onset of type 2 diabetes, the combined effects of increasing hyperglycaemia and hyperlipidaemia contribute to a further deterioration in beta-cell function and mass [5].”
BackgroundPancreatic β-cells respond to fuel pressure with an early metabolic switch
Malinowski, R. M., Ghiasi, S. M., Mandrup-Poulsen, T. R., Meier, S., Lerche, M. H., Ardenkjær‐Larsen, J. H., & Jensen, P. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-72348-1 · Cited by 9
Barrientos‐Alvarado, C., Pérez, A. E. T., & Vázquez, J. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000009 · Cited by 9
Morriseau, T. S., Doucette, C. A., & Dolinsky, V. W. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00411.2021 · Cited by 10
Ynsa, M. D., Minquin, R., Rajendran, R., Pinheiro, T., & Watt, F. (2012) · Microscopy and Microanalysis · doi:10.1017/s1431927612001547 · Cited by 8
Normalized NEFA Dynamics During an OGTT After Islet Transplantation
Vethakkan, S. R., Walters, J. M., Gooley, J. L., Boston, R. C., Kay, T. W. H., Goodman, D. J., Jenkins, A. J., & Ward, G. M. (2012) · Transplantation · doi:10.1097/tp.0b013e3182696a39 · Cited by 8
Inflammation and Oxidative Stress in Adipose Tissue
Martínez‐Fernández, L., Fernández‐Galilea, M., Félix‐Soriano, E., Escoté, X., González‐Muniesa, P., & Moreno-Aliaga, M. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00004-0 · Cited by 16
Lrrc55 is a novel prosurvival factor in pancreatic islets
Makkar, G., Shrivastava, V., Hlavay, B., Pretorius, M., Kyle, B. D., Braun, A. P., Lynn, F. C., & Huang, C. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00028.2019 · Cited by 10
Characterisation of diabetes mellitus in dogs
Fall, T. (2009) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · Cited by 19
Harada, K., Wada, E., Osuga, Y., Shimizu, K., Uenoyama, R., Hirai, M. Y., Maekawa, F., Miyazaki, M., Hayashi, Y. K., Nakamura, K., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102072 · Cited by 9
Mitophagy in the adaptation to pancreatic β cell stress in diabetes
Levi-D’Ancona, E., Stendahl, A. M., Henry-Kanarek, B. A., Davidson, R. K., Walker, E. M., & Soleimanpour, S. A. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.009 · Cited by 10
Metabolic reprogramming of pancreatic beta cells in type 2 diabetes and its therapeutic strategy
Miao, L., Miao, R., Yao, Y., Fang, X., Guan, H., Tian, J., & Tong, X. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102938 · Cited by 10
Varra, F., Theodosis‐Nobelos, P., Varra, V., & Varras, M. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47121063 · Cited by 8
“In the early stages of IR, pancreatic β -cells become hyperfunctional in an attempt to increase insulin secretion and maintain normal plasma glucose levels [17].”
Zhao, D., Yin, D., Wang, X., Li, Y., He, M., Hu, J., Lin, S., & Yang, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21879 · Cited by 11
Reevaluating Goals of Insulin Therapy: Perspectives from Large Clinical Trials
Riddle, M. C., & Yuen, K. C. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.003 · Cited by 7
Role of K ATP channels in β‐cell resistance to oxidative stress
Drews, G., & Düfer, M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01644.x · Cited by 9
“Molecular mechanisms of glucolipotoxicity, the linkage to oxidative stress, and implications for the pathogenesis of T2DM are summarized in an excellent review by Poitout and Robertson [2].”
BackgroundInfluentialRaghavan, S., Malayaperumal, S., Mohan, V., & Balasubramanyam, M. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03922-4 · Cited by 8
Koike, S., Hsu, M.-F., Bettaieb, A., Chu, B., Matsumoto, N., Morisseau, C. H. P., Havel, P. J., Huising, M. O., Hammock, B. D., & Haj, F. G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.029 · Cited by 8
Type 2 Diabetes: Etiology, Epidemiology, Pathogenesis, Treatment
Burns, C., & Sirisena, I. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_34 · Cited by 9
Luo, Y., Wang, T., Chen, Z., & Zhang, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1086667 · Cited by 8
Type 2 Diabetes: Etiology, Epidemiology, Pathogenesis, and Treatment
Burns, C., & Francis, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_34 · Cited by 13
Beta‐cell injury in Ncb5or‐null mice is exacerbated by consumption of a high‐fat diet
Guo, Y., Xu, M., Deng, B., Frontera, J. R., Kover, K. L., Aires, D., Ding, H., Carlson, S. E., TURK, J. W., Wang, W., et al. (2011) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100309 · Cited by 7
Irace, C., Rossetti, M., Carallo, C., Morano, S., Vespertini, V., Mandosi, E., Maranghi, M., Fiorentino, R., Filetti, S., & Gnasso, A. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0261-5 · Cited by 7
“Numerous factors can contribute to the loss of beta-cell mass and function, including glucotoxicity, lipotoxicity, islet-cell amyloidosis, circulating proinflammatory cytokines, and environmental factors [16–19].”
BackgroundFontès, G., Hagman, D. K., Latour, M. G., Semache, M., & Poitout, V. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.020 · Cited by 7
“In vitro studies have shown that chronically elevated levels of fatty acids, in conjunction with high glucose, inhibit insulin secretion and insulin gene expression and promote beta-cell death (reviewed in (6)).”
BackgroundSelf-citationFadini, G. P., Tura, A., Pacini, G., Avogaro, A., & de Kreutzenberg, S. V. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.002 · Cited by 7
The triumvirate of beta-cell regeneration: solutions and bottlenecks to curing diabetes
Singh, S. P., & Ninov, N. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180067nn · Cited by 7
Luppi, P., Drain, N. P., To, R., Stolz, D. B., Wallace, C. T., Watkins, S. C., & Drain, P. F. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.147 · Cited by 10
Kowluru, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114138 · Cited by 7
Parks, S. Z., Gao, T. X., Awuapura, N. J., Ayathamattam, J., CHABOSSEAU, P. L., Marchetti, P., Johnson, P., Bosco, D., Kalvakolanu, D. V., Valdivia, H. H., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14101 · Cited by 10
Free Radicals and Metabolic Disorders
Cohen, G., Riahi, Y., & Sasson, S. (2012) · Wiley eBooks · doi:10.1002/9781119953678.rad057 · Cited by 8
Liao, Y., Han, Y. Y., Cao, C., Song, H., & Hu, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01907-1 · Cited by 6
“The direct effect of AIP may reflect other mechanisms, such as increased small dense low-density lipoprotein particles leading to oxidative stress and vascular endothelial dysfunction [66], as well as lipid peroxidation and pancreatic β-cell apoptosis [67].”
Sakayanathan, P., Loganathan, C., & Palvannan, T. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70058 · Cited by 7
Gojani, E. G., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010421 · Cited by 9
Lai, K. Z. H., Semnani‐Azad, Z., Retnakaran, R. R., Harris, S. B., & Hanley, A. J. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.07.025 · Cited by 9
Vedasree, N., Peddanna, K., Rajasekhar, A., Parthasarathi, C., Munirajeswari, P., Sireesha, Y., & Chippada, A. R. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114856 · Cited by 7
Al‐Romaiyan, A., Persaud, S. J., & Jones, P. M. (2023) · Molecules · doi:10.3390/molecules29010194 · Cited by 9
Brown, J. E. P. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412446713 · Cited by 10
Abd-Ellah, H. F., & Abou-zeid, N. R. A. (2017) · Ultrastructural Pathology · doi:10.1080/01913123.2017.1286422 · Cited by 6
“β-cell insulin content, insulin secretion, and early cell death [42].”
BackgroundIslet adaptation in GIP receptor knockout mice
Åhrén, B., Yamada, Y., & Seino, Y. (2019) · Peptides · doi:10.1016/j.peptides.2019.170152 · Cited by 6
Law, C. J., Ashcroft, H. A., Zheng, W., & Sexton, J. Z. (2014) · Assay and Drug Development Technologies · doi:10.1089/adt.2014.591 · Cited by 6
Chundru, S. A., Harajli, A., Hali, M., Gleason, N. F., Gamage, S., & Kowluru, A. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000354 · Cited by 6
CARD9 Mediates Pancreatic Islet Beta-Cell Dysfunction Under the Duress of Hyperglycemic Stress
Gamage, S., Hali, M., Chen, F., & Kowluru, A. (2022) · Cellular Physiology and Biochemistry · doi:10.33594/000000508 · Cited by 6
Broek, M., de Heide, L. J. M., Veeger, N. J. G. M., van der Wal-Oost, A. M., & Beek, V. A. (2016) · Obesity Facts · doi:10.1159/000446744 · Cited by 12
Cai, Y., Lydic, T. A., Turkette, T., Reid, G. E., & Olson, L. K. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.010 · Cited by 6
β‐Cell mass and function in human type 2 diabetes
Marchetti, P., & Ferrannini, E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch24 · Cited by 12
Silva, D. N. D. A., Monajemzadeh, S., Casarin, M., Chalmers, J. C., Lubben, J., Magyar, C. E., Tetradis, S., & Pirih, F. Q. M. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14051 · Cited by 5
Betulinic acid and obesity-related disorders
Azevedo, L. F., Ferraz, R., Vieira, M., Prudêncio, C., & Fernandes, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1674713 · Cited by 6
“Chronic exposure to fatty acids leads to “ glucolipotoxicity, ” which impairs the β -cells ’ ability to release insulin in response to glucose (Poitout and Robertson, 2008).”
Review Article: Overview of Clinical Genetics of Diabetes Mellitus
Asamoah, A., & Ahima, R. S. (2026) · Genes · doi:10.3390/genes17020215 · Cited by 6
“Relative insulin insufficiency in T2D is attributed to an intrinsic insulin secretory defect and metabolic stress caused by glucotoxicity and lipotoxicity [11,12].”
Leahy, J. L., & Pratley, R. E. (2011) · Translational endocrinology & metabolism · doi:10.1210/team.9781879225824.ch1 · Cited by 9
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.